Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 17, 2015

Study Completion Date

March 17, 2015

Conditions
Breast Cancer
Interventions
DEVICE

SPY Elite Imaging

A camera that is directed into the axillary cavity to try to capture an image of the tumor site labeled with Indocyanine green before and after excising sentinel nodes

DRUG

Indocyanine Green

"started at 1mg /mL~If fluorescence is not detected with this dose, then it will be increased by 50%."

DRUG

Isosulfan blue

"3 to 5 mL~If fluorescence is not detected with this dose, then it will be increased by 50%."

DRUG

99technetium-sulfur colloid radiolabel

Trial Locations (1)

94305

Stanford University, School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01771666 - Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer | Biotech Hunter | Biotech Hunter